tradingkey.logo
搜尋

Merit Medical Systems Inc

MMSI
添加自選
71.090USD
+1.640+2.36%
收盤 07/02, 13:00美東報價延遲15分鐘
4.21B總市值
30.26本益比TTM

Merit Medical Systems Inc

71.090
+1.640+2.36%
查看詳細走勢圖
TradingKey 图表
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+2.36%

5天

-0.89%

1月

+17.21%

6月

-17.77%

今年開始到現在

-19.34%

1年

-24.03%

關鍵數據
70.050今開
71.200最高
638.53K成交量
30.26本益比TTM
15.21本益比動
--股利TTM
1.08%換手率
69.450昨收
69.550最低
37.82M成交額
35.02本益比靜
2.76市淨率
0.00%股息率 TTM
5.37%ROA
96.74052週最高
0.93量比
120.36M淨利潤
59.29M總股本
2.3490每股盈餘TTM
0.55Beta
9.12%ROE
59.74052週最低
2.38%振幅
48.39%毛利率
4.21B總市值
5.57回報/風險
1.82%風險率

TradingKey Merit Medical Systems Inc股票評分

單位: USD 更新時間: 2026-07-02

操作建議

Merit Medical Systems Inc當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名23/204位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為91.18。中期看,股價處於平穩狀態。近一個月,市場表現較強,技術面和基本面綜合得分較高,較強的走勢獲得基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Merit Medical Systems Inc評分

相關信息

行業排名
23 / 204
全市場排名
77 / 4565
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

Merit Medical Systems Inc亮點

亮點風險
Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. It also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.
業績高增長
公司營業收入穩步增長,連續3年增長20.56%
利潤高增長
公司淨利潤處於行業前列,最新年度總收入1.52B美元
估值低估
公司最新PE估值30.26,處於3年歷史低位
機構加倉
最新機構持股69.61M股,環比增加5.73%
李安斯利持倉
明星投資者李安斯利持倉,最新持倉787.27K股

分析師目標

基於 11 分析師
買入
評級
91.182
目標均價
+31.29%
漲幅空間

Merit Medical Systems Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Merit Medical Systems Inc簡介

Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. It also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.
公司代碼MMSI
公司Merit Medical Systems Inc
CEOAronson (Martha Goldberg)
網址https://www.merit.com/

常見問題

Merit Medical Systems Inc(MMSI)的當前股價是多少?

Merit Medical Systems Inc(MMSI)的當前股價是 71.09。

Merit Medical Systems Inc 的股票代碼是什麼?

Merit Medical Systems Inc的股票代碼是MMSI。

Merit Medical Systems Inc股票的52週最高點是多少?

Merit Medical Systems Inc股票的52週最高點是96.74。

Merit Medical Systems Inc股票的52週最低點是多少?

Merit Medical Systems Inc股票的52週最低點是59.74。

Merit Medical Systems Inc的市值是多少?

Merit Medical Systems Inc的市值是4.24B。

現在Merit Medical Systems Inc(MMSI)的股票是買入、持有還是賣出?

根據分析師評級,Merit Medical Systems Inc(MMSI)的總體評級為買入,目標價格為91.18。

Merit Medical Systems Inc(MMSI)股票的每股收益(EPS TTM)是多少

Merit Medical Systems Inc(MMSI)股票的每股收益(EPS TTM)是2.17。